Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production. - Archive ouverte HAL Access content directly
Journal Articles European Heart Journal Year : 2013

Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.

(1) , (1) , (1) , (1) , (1) , (2, 3) , (4) , (1) , (1) , (1) , (1)
1
2
3
4

Abstract

AIMS: Peroxisome proliferator-activated receptor (PPAR)-α is a transcription factor controlling lipid metabolism in liver, heart, muscle, and macrophages. Peroxisome proliferator-activated receptor-α activation increases plasma HDL cholesterol and exerts hypotriglyceridaemic actions via the liver. However, the intestine expresses PPAR-α, produces HDL and chylomicrons, and is exposed to diet-derived PPAR-α ligands. Therefore, we examined the effects of PPAR-α activation on intestinal lipid and lipoprotein metabolism. METHODS AND RESULTS: The impact of PPAR-α activation was evaluated in term of HDL-related gene expression in mice, ex vivo in human jejunal biopsies and in Caco-2/TC7 cells. Apolipoprotein-AI/HDL secretion, cholesterol esterification, and trafficking were also studied in vitro. In parallel to improving plasma lipid profiles and increasing liver and intestinal expression of fatty acid oxidation genes, treatment with the dual PPAR-α/δ ligand GFT505 resulted in a more pronounced increase in plasma HDL compared with fenofibrate in mice. GFT505, but not fenofibrate, increased the expression of HDL production genes such as apolipoprotein-AI and ATP-binding cassette A1 transporter in murine intestines. A similar increase was observed upon PPAR-α activation of human biopsies and Caco-2/TC7 cells. Additionally, HDL secretion by Caco-2/TC7 cells increased. Moreover, PPAR-α activation decreased the cholesterol esterification capacity of Caco-2/TC7 cells, modified cholesterol trafficking, and reduced apolipoprotein-B secretion. CONCLUSION: Peroxisome proliferator-activated receptor-α activation reduces cholesterol esterification, suppresses chylomicron, and increases HDL secretion by enterocytes. These results identify the intestine as a target organ of PPAR-α ligands with entero-hepatic tropism to reduce atherogenic dyslipidaemia.
Fichier principal
Vignette du fichier
inserm-00730530_edited.pdf (573.91 Ko) Télécharger le fichier
Vignette du fichier
Colin_S_figure_3.pdf (350.45 Ko) Télécharger le fichier
Vignette du fichier
Eur_Heart_J_Colin_et_al.pdf (105.65 Ko) Télécharger le fichier
Vignette du fichier
Figure_1_COLIN_S_.tif (3.82 Mo) Télécharger le fichier
Vignette du fichier
Figure_2_COLIN_S.tif (1.9 Mo) Télécharger le fichier
Vignette du fichier
figure_5_Colin_S.tif (3.54 Mo) Télécharger le fichier
Vignette du fichier
Figure_6_COLIN_S.tif (4.44 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Format : Other
Origin : Files produced by the author(s)
Format : Other

Dates and versions

inserm-00730530 , version 1 (01-07-2013)

Identifiers

Cite

Sophie Colin, Olivier Briand, Véronique Touche, Kristiaan Wouters, Morgane Baron, et al.. Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.. European Heart Journal, 2013, 34 (32), pp.2566-74. ⟨10.1093/eurheartj/ehs227⟩. ⟨inserm-00730530⟩
138 View
646 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More